Literature DB >> 29269674

Specific Gastric Blood Vessels in Sinistral Portal Hypertension.

Hiroteru Kamimura1, Toru Ishikawa2, Noriko Ishihara3, Shuji Terai1.   

Abstract

Entities:  

Keywords:  pancreatic cancer; sinistral portal hypertension

Year:  2017        PMID: 29269674      PMCID: PMC5919872          DOI: 10.2169/internalmedicine.9699-17

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


× No keyword cloud information.
Advanced pancreatic cancer is a highly uncontrollable disease that is encountered throughout the world. Occlusion of the splenic vein as a result of hematemesis is suspected to be a cause sinistral portal hypertension (SPH) in patients with pancreatic cancer (1). We herein report the case of a patient with pancreatic cancer in whom the specific gastric blood vessel that caused bleeding was identified. Abdominal CT and macroscopic pathology showed a tumor of the pancreas that invaded the splenic vein (Picture 1). A large amount of melena was observed in the gastric varices of the upper stomach (Picture 2. white arrow); bridging vessels were identified among these varices that have not been previously reported (Picture 2. yellow arrow). Microscopy revealed that the gastric varices were located in the submucosa (Picture 3. white arrow) and the bridging vessels were located in the mucosal layer (Picture 4. yellow arrow). A healed mucosal layer was observed above these vessels, which we recognized as the bleeding point on autopsy (Picture 4). The development of bridging vessels in the mucosal layer due to SPH may be a cause of melena (2).
Picture 1.
Picture 2.
Picture 3.
Picture 4.

The authors state that they have no Conflict of Interest (COI).
  2 in total

1.  Clinical and endoscopic features of gastric varices secondary to splenic vein occlusion.

Authors:  Takahiro Sato; Katsu Yamazaki; Jun Akaike; Jouji Toyota; Yoshiyasu Karino; Takumi Ohmura
Journal:  Hepatol Res       Date:  2008-05-20       Impact factor: 4.288

Review 2.  Left-sided portal hypertension.

Authors:  Seyfettin Köklü; Sahin Coban; Osman Yüksel; Mehmet Arhan
Journal:  Dig Dis Sci       Date:  2007-03-24       Impact factor: 3.487

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.